Thrombospondin 1 is a key mediator of TGF beta-mediated cell contractility in systemic sclerosis via a MEK/ERK-dependent mechanism
Yi‐Lung Chen(National Taiwan University), Mark Eastwood, CP Denton(The Royal Free Hospital), SW Xu, A Leask, Laura Kennedy, Dietmar Abraham(Medical University of Vienna), Casilda G. Black
UCL Discovery (University College London)
May 1, 2009
Cited by 0
Related Papers
Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach
|Annals of the Rheumatic Diseases|2003|769
Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial
|Annals of the Rheumatic Diseases|2010|503
Raf-1-associated Protein Phosphatase 2A as a Positive Regulator of Kinase Activation
|Journal of Biological Chemistry|2000|219
Open-Label Trial of Anti-TNF-α in Dermato- and Polymyositis Treated Concomitantly with Methotrexate
|European Neurology|2008|99